The primary objective of this study was to evaluate the clinical feasibility, safety, and surgical characteristics of the EasyStars™ High Density Mapping Catheterin in patients with complex arrhythmias.
Clinical diagnosis: Ventricular tachycardia (VT)
Patients aged between 18 and 80 years;
Confirmed diagnosis of ventricular tachycardia (VT) via electrocardiogram (ECG) or 24-hour Holter monitoring;
The patient has experienced at least one episode of VT in the past 6 months and exhibits symptoms of sustained or paroxysmal ventricular tachycardia;
Uncontrolled heart failure (New York Heart Association functional class III-IV);
History of acute or progressive myocardial infarction;
Severe pulmonary, hepatic, or renal disease;
Valvular heart disease or congenital heart disease;
Single group
EasyStars™ High Density Mapping Catheter
DeviceAll patients underwent treatment for complex arrhythmias using EasyStars™ High Density Mapping Catheter.
primary efficacy endpoint
The proportion of immediate success (all participating subjects) in treating rapid arrhythmias using EasyStars™ High Density Mapping Catheter in combination with cardiac ablation catheters and three-dimensional cardiac electrophysiology mapping systems
Click on the lead sponsor to view all of their trials.
Shanghai MicroPort EP MedTech Co., Ltd.
Lead sponsor
Shanghai General Hospital, China
Collaborator
This trial is not recruiting at the moment. You can still explore other options:
